Lawrence S. Cohen

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

J. H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · 1987 · 735 citations

Medicine, Cardiology, Internal Medicine +11

Increasing Womenʼs Leadership in Academic Medicine

Janet Bickel, Diane W. Wara, Barbara Atkinson et al. · Academic Medicine · 2002 · 362 citations

Management, Leadership, Medical Education +17

Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.

David O. Williams, Jeffrey Borer, Eugene Braunwald et al. · Circulation · 1986 · 292 citations

Medicine, Cardiology, Pharmacotherapy +14

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.

Hiltrud S. Mueller, Lawrence S. Cohen, Eugene Braunwald et al. · Circulation · 1992 · 233 citations

Medicine, Cardiology, Internal Medicine +10